Abstract
Research Institute at Harbor-UCLA Medical Center. “Current smokers also should carefully consider this mortality risk before beginning or continuing combined hormone therapy,” he added. These findings were in contrast to the results of most case-control studies that have not found an increased risk, according to Bruce Johnson, MD, director of the Lung Cancer Program at the Dana-Farber/Harvard Cancer Center, who was not involved in the research. “This [Women’s Health Initiative study] is likely more accurate since it is . . . a prospective randomized study,” he said. These latest findings may encourage additional studies on the effects of hormones on the development and progression of lung cancer. The investigators also hope that their results will prompt physicians and patients to reassess the use of combined hormone therapy for the treatment of menopausal symptoms.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
